Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Lanping Zhou"'
Autor:
Chenxuan Gao, Shizhen Gao, Renpei Zhao, Peimin Shen, Xiaorui Zhu, Yane Yang, Conghao Duan, Yansi Wang, Huan Ni, Lanping Zhou, Yunfang Xiang, MeiJu Li, Zhao Xu, Yibing Wang, Haijie Yang, Chuanwei Zhao
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-12 (2024)
Abstract This study aims to explore the relationship between the Systemic Immune-Inflammation Index (SII) and Cardiovascular-Kidney-Metabolic (CKM) Syndrome and its components. Data from the National Health and Nutrition Examination Survey (NHANES) f
Externí odkaz:
https://doaj.org/article/8422cdcd44d74bf3b15f3dcfd69f952d
Autor:
Xiufeng Xie, Lusong Tian, Yan Zhao, Fang Liu, Shuyang Dai, Xinglu Gu, Yuxin Ye, Lanping Zhou, Xinmiao Liu, Yulin Sun, Xiaohang Zhao
Publikováno v:
Cell Death and Disease, Vol 14, Iss 1, Pp 1-16 (2023)
Abstract Esophageal squamous cell carcinoma (ESCC) is one of the fatal malignancies worldwide. It has an increased propensity to metastasize via lymphogenous routes in an early stage. The prognosis of patients with lymph node metastases (LNM) is ofte
Externí odkaz:
https://doaj.org/article/d4fe9f2bcaf8458a834d76383f70f434
Autor:
Yulin Sun, Zhengguang Guo, Xiaoyan Liu, Lijun Yang, Zongpan Jing, Meng Cai, Zhaoxu Zheng, Chen Shao, Yefan Zhang, Haidan Sun, Li Wang, Minjie Wang, Jun Li, Lusong Tian, Yue Han, Shuangmei Zou, Jiajia Gao, Yan Zhao, Peng Nan, Xiufeng Xie, Fang Liu, Lanping Zhou, Wei Sun, Xiaohang Zhao
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-15 (2022)
More sensitive and specific non-invasive biomarkers are desired for early detection of cancer. Here, the authors show a protein signature in the urine that increases sensitivity for colorectal cancer detection when combined with fecal immunochemical
Externí odkaz:
https://doaj.org/article/cb3247a8cb6d43b5bf522777e805b002
Publikováno v:
Cancer Medicine, Vol 7, Iss 5, Pp 1802-1813 (2018)
Abstract Stathmin‐1 is a microtubule depolymerization protein that regulates cell division, growth, migration, and invasion. Overexpression of stathmin‐1 has been observed to be associated with metastasis, poor prognosis, and chemoresistance in v
Externí odkaz:
https://doaj.org/article/6eeee431b922483b9584f5ddf9610db5
Publikováno v:
PLoS ONE, Vol 10, Iss 3, p e0121920 (2015)
Many studies have shown that the quantity and dynamics of circulating tumor cells (CTCs) in peripheral blood of patients afflicted with solid tumours have great relevance in therapeutic efficacy and prognosis. Different methods based on various strat
Externí odkaz:
https://doaj.org/article/6b5d86a18cfe45fea9b956bbab14defe
Autor:
Yang Xu, Zhengwei Lin, Nan Zhao, Lanping Zhou, Fang Liu, Zbigniew Cichacz, Lin Zhang, Qimin Zhan, Xiaohang Zhao
Publikováno v:
PLoS ONE, Vol 9, Iss 6, p e100127 (2014)
Cisplatin-based chemotherapy is currently the standard treatment for locally advanced esophageal cancer. Cisplatin has been shown to induce both apoptosis and necrosis in cancer cells, but the mechanism by which programmed necrosis is induced remains
Externí odkaz:
https://doaj.org/article/39129caa3fbf4012938eaf3d821fe6cd
Publikováno v:
PLoS ONE, Vol 9, Iss 9, p e107204 (2014)
The protocatechuic acid ethyl ester ethyl-3,4-dihydroxybenzoate is an antioxidant found in the testa of peanut seeds. Previous studies have shown that ethyl-3,4-dihydroxybenzoate can effectively reduce breast cancer cell metastasis by inhibiting prol
Externí odkaz:
https://doaj.org/article/e1ce55adbd7641b8b51f2eaae113ada4
Purpose: Second mitochondria-derived activator of caspase (Smac) regulates chemotherapy-induced apoptosis. Smac mimetics have been tested in clinical trials as chemosensitizers. We determined the role of Smac in modulating the chemosensitivity of eso
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4dd1f6ebb365be74c9b6777fc3d12d08
https://doi.org/10.1158/1078-0432.c.6519533.v1
https://doi.org/10.1158/1078-0432.c.6519533.v1
Autor:
Lusong Tian, Zongpan Jing, Xiufeng Xie, Peng Nan, Jiajia Gao, Jun Li, Yan Sun, Xiaohang Zhao, Ying Zhu, Fang Liu, Fangfei Niu, Yan Zhao, Lanping Zhou, Yulin Sun
Publikováno v:
Cancer Letters. 519:46-62
Sorafenib and lenvatinib are approved first-line targeted therapies for advanced liver cancer, but most patients develop acquired resistance. Herein, we found that sorafenib induced extensive acetylation changes towards a more energetic metabolic phe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba60fa3b95c04c02b3f39028ef7265e3
https://doi.org/10.1016/j.canlet.2021.06.016
https://doi.org/10.1016/j.canlet.2021.06.016